Apellis Pharmaceuticals Ratios (2020-2025) | APLS

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 97.36%99.92%91.33%99.50%93.74%87.09%82.59%91.18%79.70%86.40%88.27%88.43%82.95%80.78%79.40%92.37%94.65%
EBT Margin 2,562.64%-21,421.21%48.28%-35,183.15%-3,461.43%-244.79%-957.70%-952.65%-865.18%-738.92%-395.79%-128.30%-126.82%-59.54%-38.45%-18.80%-28.88%-16.97%-55.09%-23.35%47.17%
EBIT Margin 2,520.69%-20,054.49%52.05%-31,185.71%-2,265.40%-148.29%-897.00%-910.57%-693.41%-723.88%-390.41%-126.82%-124.17%-57.74%-36.03%-14.74%-24.02%-12.31%-49.96%-18.65%48.67%
EBITDA Margin 4,278.08%-21,329.41%31.96%-35,216.69%-3,464.64%-245.50%-965.89%-962.58%-866.44%-722.94%-396.20%-128.52%-127.27%-62.20%-38.54%-18.78%-29.07%-17.18%-55.14%-23.34%47.08%
Operating Margin 2,520.69%-20,054.49%52.05%-31,185.71%-2,265.40%-148.29%-897.00%-910.57%-693.41%-723.88%-390.41%-126.82%-124.17%-57.74%-36.03%-14.74%-24.02%-12.31%-49.96%-18.65%48.67%
Net Margin 2,562.64%-21,421.21%48.28%-35,183.15%-3,461.43%-245.37%-966.10%-955.62%-867.20%-732.43%-396.46%-128.51%-127.03%-60.51%-38.56%-18.86%-29.19%-17.09%-55.29%-23.63%47.04%
FCF Margin 2,775.81%-16,031.27%56.51%-20,695.99%-2,990.74%-186.63%-776.34%-658.10%-701.00%-624.78%-396.64%-158.50%-153.20%-66.93%-77.34%-4.22%17.32%9.10%-32.03%2.46%23.62%
Efficiency
Inventory Average 2.70M8.98M24.57M40.65M54.10M72.73M85.60M94.35M100.88M122.45M153.82M157.03M136.91M101.23M81.94M101.73M121.91M
Assets Average 779.52M819.22M864.45M885.35M755.02M612.80M703.73M1,013.81M1,074.18M937.70M816.55M869.54M947.22M866.90M803.47M810.33M868.21M903.17M893.46M846.17M814.34M940.06M
Equity Average 245.53M168.95M155.20M128.11M-44.92M-99.41M70.67M330.45M63.91M-13.50M238.64M291.00M378.76M288.84M213.40M230.60M265.50M250.72M232.83M196.38M160.26M278.74M
Invested Capital 259.00M232.06M105.84M204.56M51.66M-141.49M-57.33M198.66M462.24M-334.42M307.42M169.87M412.12M345.40M232.27M194.52M266.68M264.33M237.12M228.54M164.22M156.31M494.75M
Asset Utilization Ratio 0.290.280.330.420.090.080.090.120.090.120.190.310.490.650.720.790.870.920.931.08
Leverage & Solvency
Interest Coverage Ratio -25.21-16.72-13.6413.54-29.84-51.58-56.09-29.62-15.11-17.59-19.35-21.20-23.25-16.41-18.75-11.42-8.91-3.15-3.77-2.27-7.54-2.9819.79
Debt to Equity 1.381.511.572.192.311.13
Debt Ratio 0.400.400.410.450.440.43
Equity Ratio 0.380.270.140.210.06-0.20-0.110.230.40-0.330.350.220.420.380.280.250.320.290.260.260.200.190.38
Times Interest Earned -25.21-16.72-13.6413.54-29.84-51.58-56.09-29.62-15.11-17.59-19.35-21.20-23.25-16.41-18.75-11.42-8.91-3.15-3.77-2.27-7.54-2.9819.79
Valuation
Enterprise Value -646.69M-832.85M-728.16M-877.65M-723.67M-599.01M-430.31M-700.55M-965.30M-852.80M-708.55M-553.07M-766.36M-617.34M-453.50M-352.30M-327.03M-361.43M-398.24M-412.61M-359.83M-371.47M-480.63M
Return Ratios
Return on Sales 25.63%-214.21%0.48%-1.29%-351.83%-34.61%-2.45%-9.66%-9.56%-8.67%-7.32%-3.96%-1.29%-1.27%-0.61%-0.39%-0.19%-0.29%-0.17%-0.55%-0.24%0.47%
Return on Capital Employed -0.29%-0.30%-0.53%-0.61%-0.94%-0.61%-0.52%-0.63%-0.92%-0.88%-0.79%-0.88%-0.93%-0.68%-0.45%-0.31%-0.23%-0.28%-0.31%0.12%
Return on Invested Capital -7.59%-1.64%-7.77%38.66%-2.49%-2.20%-1.62%-2.06%-2.43%-1.76%-1.19%-0.90%-0.71%-0.95%-1.19%0.24%
Return on Assets -0.28%-0.36%-0.56%-0.78%-1.06%-0.69%-0.59%-0.68%-0.80%-0.79%-0.69%-0.70%-0.66%-0.51%-0.38%-0.28%-0.22%-0.26%-0.28%0.05%
Return on Equity -1.54%-2.52%9.36%4.81%-10.56%-2.12%-9.99%46.97%-2.73%-2.37%-1.73%-2.10%-2.48%-1.81%-1.25%-1.00%-0.85%-1.14%-1.42%0.16%